{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T16:28:20Z","timestamp":1792600100544,"version":"4.5.0"},"reference-count":139,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,9,15]],"date-time":"2020-09-15T00:00:00Z","timestamp":1600128000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"DOI":"10.3389\/fonc.2020.01751","type":"journal-article","created":{"date-parts":[[2020,9,15]],"date-time":"2020-09-15T11:26:45Z","timestamp":1600169205000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":77,"title":["HPV Detection in Head and Neck Squamous Cell Carcinomas: What Is the Issue?"],"prefix":"10.3389","volume":"10","author":[{"given":"Jeremy Gbenakpon","family":"Augustin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Lepine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aurelien","family":"Morini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anais","family":"Brunet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Veyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camille","family":"Brochard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haitham","family":"Mirghani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e9l\u00e8ne","family":"P\u00e9r\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9cile","family":"Badoual","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,9,15]]},"reference":[{"key":"B1","year":"2020","journal-title":"Global Cancer Observatory."},{"key":"B2","doi-asserted-by":"publisher","first-page":"4294","DOI":"10.1200\/JCO.2011.36.4596","article-title":"Human papillomavirus and rising oropharyngeal cancer incidence in the United States.","volume":"29","author":"Chaturvedi","year":"2011","journal-title":"J Clin Oncol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1093\/jnci\/92.9.709","article-title":"Evidence for a causal association between human papillomavirus and a subset of head and neck cancers.","volume":"92","author":"Gillison","year":"2000","journal-title":"J Natl Cancer Inst."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1944","DOI":"10.1056\/NEJMoa065497","article-title":"Case-control study of human papillomavirus and oropharyngeal cancer.","volume":"356","author":"D\u2019Souza","year":"2007","journal-title":"N Engl J Med."},{"key":"B5","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1056\/NEJMoa0912217","article-title":"Human papillomavirus and survival of patients with oropharyngeal cancer.","volume":"363","author":"Ang","year":"2010","journal-title":"N Engl J Med."},{"key":"B6","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1016\/j.amjoto.2019.06.007","article-title":"HPV status in patients with nasopharyngeal carcinoma in the United States: a SEER database study.","volume":"40","author":"Wotman","year":"2019","journal-title":"Am J Otolaryngol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1002\/hed.24978","article-title":"Human papillomavirus and nasopharyngeal cancer.","volume":"40","author":"Verma","year":"2018","journal-title":"Head Neck."},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djv403","article-title":"HPV involvement in head and neck cancers: comprehensive assessment of biomarkers in 3680 patients.","volume":"108","author":"Castellsagu\u00e9","year":"2016","journal-title":"J Natl Cancer Inst."},{"key":"B9","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1158\/1055-9965.EPI-15-0869","article-title":"Prevalence, clinicopathological characteristics, and outcome of human papillomavirus-associated oropharyngeal cancer in Southern Chinese patients.","volume":"25","author":"Lam","year":"2016","journal-title":"Cancer Epidemiol Biomarkers Prev."},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-017-3789-0","article-title":"Prevalence and types of high-risk human papillomaviruses in head and neck cancers from Bangladesh.","volume":"17","author":"Shaikh","year":"2017","journal-title":"BMC Cancer."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1002\/hed.24429","article-title":"Human papillomavirus integration pattern and demographic, clinical, and survival characteristics of patients with oropharyngeal squamous cell carcinoma.","volume":"38","author":"Lim","year":"2016","journal-title":"Head Neck."},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.oraloncology.2019.104522","article-title":"Distinct biomarker and behavioral profiles of human papillomavirus-related oropharynx cancer patients by age.","volume":"101","author":"Fakhry","year":"2020","journal-title":"Oral Oncol."},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-66323-z","article-title":"Age-independent increasing prevalence of Human Papillomavirus-driven oropharyngeal carcinomas in North-East Italy.","volume":"10","author":"Del Mistro","year":"2020","journal-title":"Sci Rep."},{"key":"B14","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.oraloncology.2018.06.013","article-title":"Oropharyngeal cancer is no longer a disease of younger patients and the prognostic advantage of human Papillomavirus is attenuated among older patients: analysis of the National cancer database.","volume":"83","author":"Rettig","year":"2018","journal-title":"Oral Oncol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.radonc.2017.10.018","article-title":"MARCH collaborative group. prognostic impact of HPV-associated p16-expression and smoking status on outcomes following radiotherapy for oropharyngeal cancer: the MARCH-HPV project.","volume":"126","author":"Lassen","year":"2018","journal-title":"Radiother Oncol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.oraloncology.2019.06.021","article-title":"Standard of care vs reduced-dose chemoradiation after induction chemotherapy in HPV+ oropharyngeal carcinoma patients: the Quarterback trial.","volume":"95","author":"Misiukiewicz","year":"2019","journal-title":"Oral Oncol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1177\/0194599815592157","article-title":"HPV positive oropharyngeal carcinoma: a systematic review of treatment and prognosis.","volume":"153","author":"Wang","year":"2015","journal-title":"Otolaryngol Head Neck Surg."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1093\/annonc\/mdr006","article-title":"Survival and human papillomavirus in oropharynx cancer in TAX 324: a subset analysis from an international phase III trial.","volume":"22","author":"Posner","year":"2011","journal-title":"Ann Oncol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"3930","DOI":"10.1200\/JCO.2013.54.5228","article-title":"p16 protein expression and human papillomavirus status as prognostic biomarkers of nonoropharyngeal head and neck squamous cell carcinoma.","volume":"32","author":"Chung","year":"2014","journal-title":"J Clin Oncol."},{"key":"B20","year":"","journal-title":"TNM Classification of Malignant Tumours."},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD012939.pub2","article-title":"De-intensified adjuvant (chemo)radiotherapy versus standard adjuvant chemoradiotherapy post transoral minimally invasive surgery for resectable HPV-positive oropharyngeal carcinoma.","volume":"12","author":"Howard","year":"2018","journal-title":"Cochrane Database Syst Rev."},{"key":"B22","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.ejca.2019.10.025","article-title":"Concurrent cisplatin or cetuximab with radiotherapy for HPV-positive oropharyngeal cancer: medical resource use, costs, and quality-adjusted survival from the De-ESCALaTE HPV trial.","volume":"124","author":"Jones","year":"2020","journal-title":"Eur J Cancer."},{"key":"B23","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1093\/jnci\/djz224","article-title":"PIK3CA mutation in HPV-associated OPSCC patients receiving deintensified chemoradiation.","volume":"112","author":"Beaty","year":"2019","journal-title":"J Natl Cancer Inst."},{"key":"B24","doi-asserted-by":"publisher","first-page":"559","DOI":"10.5858\/arpa.2017-0286-CP","article-title":"Human papillomavirus testing in head and neck carcinomas: guideline from the college of American pathologists.","volume":"142","author":"Lewis","year":"2018","journal-title":"Arch Pathol Lab Med."},{"key":"B25","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1038\/nature16481","article-title":"Structure of the E6\/E6AP\/p53 complex required for HPV-mediated degradation of p53.","volume":"529","author":"Martinez-Zapien","year":"2016","journal-title":"Nature."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1016\/0092-8674(90)90409-8","article-title":"The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53.","volume":"63","author":"Scheffner","year":"1990","journal-title":"Cell."},{"key":"B27","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.tim.2017.07.007","article-title":"The HPV E6\/E7 oncogenes: key factors for viral carcinogenesis and therapeutic targets.","volume":"26","author":"Hoppe-Seyler","year":"2018","journal-title":"Trends Microbiol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1006\/excr.1997.3824","article-title":"The tumor suppressor protein p16INK4a.","volume":"237","author":"Serrano","year":"1997","journal-title":"Exp Cell Res."},{"key":"B29","doi-asserted-by":"publisher","first-page":"2620","DOI":"10.1128\/jvi.78.5.2620-2626.2004","article-title":"Roles of the E6 and E7 proteins in the life cycle of low-risk human papillomavirus type 11.","volume":"78","author":"Oh","year":"2004","journal-title":"J Virol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"2130","DOI":"10.1073\/pnas.1009933108","article-title":"Human papillomavirus E7 oncoprotein induces KDM6A and KDM6B histone demethylase expression and causes epigenetic reprogramming.","volume":"108","author":"McLaughlin-Drubin","year":"2011","journal-title":"Proc Natl Acad Sci USA."},{"key":"B31","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1093\/jnci\/djp017","article-title":"E6 and E7 gene silencing and transformed phenotype of human papillomavirus 16-positive oropharyngeal cancer cells.","volume":"101","author":"Rampias","year":"2009","journal-title":"JNCI J Natl Cancer Inst."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1073\/pnas.95.3.1189","article-title":"Inhibition of HPV-16 E6\/E7 immortalization of normal keratinocytes by hairpin ribozymes.","volume":"95","author":"Alvarez-Salas","year":"1998","journal-title":"Proc Natl Acad Sci USA."},{"key":"B33","doi-asserted-by":"publisher","first-page":"5694","DOI":"10.1158\/1078-0432.CCR-05-0587","article-title":"Tissue distribution of human papillomavirus 16 DNA integration in patients with tonsillar carcinoma.","volume":"11","author":"Begum","year":"2005","journal-title":"Clin Cancer Res."},{"key":"B34","doi-asserted-by":"publisher","first-page":"2101","DOI":"10.1101\/gad.11.16.2101","article-title":"The human papillomavirus E7 oncoprotein can uncouple cellular differentiation and proliferation in human keratinocytes by abrogating p21Cip1-mediated inhibition of cdk2.","volume":"11","author":"Jones","year":"1997","journal-title":"Genes Dev."},{"key":"B35","doi-asserted-by":"crossref","first-page":"4417","DOI":"10.1128\/JVI.63.10.4417-4421.1989","article-title":"The E6 and E7 genes of the human papillomavirus type 16 together are necessary and sufficient for transformation of primary human keratinocytes.","volume":"63","author":"M\u00fcnger","year":"1989","journal-title":"J Virol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1016\/S1470-2045(10)70017-6","article-title":"HPV-associated head and neck cancer: a virus-related cancer epidemic.","volume":"11","author":"Marur","year":"2010","journal-title":"Lancet Oncol."},{"key":"B37","author":"El-Naggar","year":"2017","journal-title":"WHO Classification of Head and Neck Tumours."},{"key":"B38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.pvr.2018.05.003","article-title":"HPV E6 oncoproteins and nucleic acids in neck lymph node fine needle aspirates and oral samples from patients with oropharyngeal squamous cell carcinoma.","volume":"6","author":"Chernesky","year":"2018","journal-title":"Papillomavirus Res."},{"key":"B39","doi-asserted-by":"publisher","first-page":"6262","DOI":"10.1158\/1078-0432.CCR-11-0388","article-title":"Evaluation of human papilloma virus diagnostic testing in oropharyngeal squamous cell carcinoma: sensitivity, specificity, and prognostic discrimination.","volume":"17","author":"Schache","year":"2011","journal-title":"Clin Cancer Res."},{"key":"B40","doi-asserted-by":"publisher","first-page":"2465","DOI":"10.1002\/ijc.22980","article-title":"A novel algorithm for reliable detection of human papillomavirus in paraffin embedded head and neck cancer specimen.","volume":"121","author":"Smeets","year":"2007","journal-title":"Int J Cancer."},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-24781-6","article-title":"Systematic evaluation of RNA quality, microarray data reliability and pathway analysis in fresh, fresh frozen and formalin-fixed paraffin-embedded tissue samples.","volume":"8","author":"Wimmer","year":"2018","journal-title":"Sci Rep."},{"key":"B42","doi-asserted-by":"publisher","first-page":"4436","DOI":"10.1093\/nar\/27.22.4436","article-title":"Analysis of chemical modification of RNA from formalin-fixed samples and optimization of molecular biology applications for such samples.","volume":"27","author":"Masuda","year":"1999","journal-title":"Nucleic Acids Res."},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0001261","article-title":"Determinants of RNA quality from FFPE samples.","volume":"2","author":"von Ahlfen","year":"2007","journal-title":"PLoS One."},{"key":"B44","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1097\/00019606-200406000-00008","article-title":"Impact of fixative on recovery of mRNA from paraffin-embedded tissue.","volume":"13","author":"Benchekroun","year":"2004","journal-title":"Diagn Mol Pathol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1002\/hed.25591","article-title":"HPV as a marker for molecular characterization in head and neck oncology: looking for a standardization of clinical use and of detection method(s) in clinical practice.","volume":"41","author":"Bussu","year":"2019","journal-title":"Head Neck."},{"key":"B46","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.jmoldx.2019.10.009","article-title":"Development and validation of a novel and rapid molecular detection method for high-risk human papillomavirus in formalin-fixed, paraffin-embedded tumor tissue.","volume":"22","author":"Mes","year":"2020","journal-title":"J Mol Diagn."},{"key":"B47","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1158\/1055-9965.EPI-14-1417","article-title":"Offering self-sampling kits for HPV testing to reach women who do not attend in the regular cervical cancer screening program.","volume":"24","author":"Arbyn","year":"2015","journal-title":"Cancer Epidemiol Biomarkers Prev."},{"key":"B48","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.jcv.2016.01.009","article-title":"Clinical validation of AnyplexTM II HPV HR detection according to the guidelines for HPV test requirements for cervical cancer screening.","volume":"76","author":"Hesselink","year":"2016","journal-title":"J Clin Virol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1002\/ijc.30516","article-title":"Diagnostic accuracy of p16INK4a immunohistochemistry in oropharyngeal squamous cell carcinomas: a systematic review and meta-analysis.","volume":"140","author":"Prigge","year":"2017","journal-title":"Int J Cancer."},{"key":"B50","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.oraloncology.2017.07.016","article-title":"Evaluation of the Xpert\u00ae HPV assay in the detection of human Papillomavirus in formalin-fixed paraffin-embedded oropharyngeal carcinomas.","volume":"72","author":"Don\u00e0","year":"2017","journal-title":"Oral Oncol."},{"key":"B51","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.yexmp.2016.12.004","article-title":"Utility of the Roche Cobas 4800 for detection of high-risk human papillomavirus in formalin-fixed paraffin-embedded oropharyngeal squamous cell carcinoma.","volume":"102","author":"Pettus","year":"2017","journal-title":"Exp Mol Pathol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.pathol.2019.02.002","article-title":"HPV detection and genotyping of head and neck cancer biopsies by molecular testing with regard to the new oropharyngeal squamous cell carcinoma classification based on HPV status.","volume":"51","author":"Veyer","year":"2019","journal-title":"Pathology."},{"key":"B53","doi-asserted-by":"publisher","first-page":"620","DOI":"10.5858\/arpa.2019-0199-OA","article-title":"Evaluation of the anyplex II HPV28 assay in the detection of human Papillomavirus in archival samples of oropharyngeal carcinomas.","volume":"144","author":"Rollo","year":"2019","journal-title":"Arch Pathol Lab Med."},{"key":"B54","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1158\/1055-9965.EPI-19-0538","article-title":"Comparison of molecular assays for HPV testing in oropharyngeal squamous cell carcinomas: a population-based study in Northern Ireland.","volume":"29","author":"Craig","year":"2020","journal-title":"Cancer Epidemiol Biomarkers Prev."},{"key":"B55","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.jmoldx.2017.11.008","article-title":"Evaluation of diagnostic utility of a high-risk human Papillomavirus PCR test on formalin-fixed, paraffin-embedded head and neck tumor tissues.","volume":"20","author":"Huho","year":"2018","journal-title":"J Mol Diagn."},{"key":"B56","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.jmoldx.2011.03.007","article-title":"Efficient DNA extraction for HPV genotyping in formalin-fixed, paraffin-embedded tissues.","volume":"13","author":"Steinau","year":"2011","journal-title":"J Mol Diagn."},{"key":"B57","doi-asserted-by":"publisher","first-page":"797","DOI":"10.14670\/HH-26.797","article-title":"Excavation of a buried treasure\u2013DNA, mRNA, miRNA and protein analysis in formalin fixed, paraffin embedded tissues.","volume":"26","author":"Klopfleisch","year":"2011","journal-title":"Histol Histopathol."},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0000537","article-title":"The isolation of nucleic acids from fixed, paraffin-embedded tissues-which methods are useful when?","volume":"2","author":"Gilbert","year":"2007","journal-title":"PLoS One."},{"key":"B59","doi-asserted-by":"publisher","first-page":"S88","DOI":"10.1016\/j.jcv.2015.10.007","article-title":"Detection of alpha human papillomaviruses in archival formalin-fixed, paraffin-embedded (FFPE) tissue specimens.","author":"Kocjan","year":"2016","journal-title":"J Clin Virol."},{"key":"B60","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.ctrv.2015.10.009","article-title":"From HPV-positive towards HPV-driven oropharyngeal squamous cell carcinomas.","volume":"42","author":"Boscolo-Rizzo","year":"2016","journal-title":"Cancer Treat Rev."},{"key":"B61","doi-asserted-by":"publisher","first-page":"3235","DOI":"10.1200\/JCO.2015.61.6995","article-title":"Epidemiology of human papillomavirus-positive head and neck squamous cell carcinoma.","volume":"33","author":"Gillison","year":"2015","journal-title":"J Clin Oncol."},{"key":"B62","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1038\/bjc.2013.63","article-title":"Validation of a novel diagnostic standard in HPV-positive oropharyngeal squamous cell carcinoma.","volume":"108","author":"Schache","year":"2013","journal-title":"Br J Cancer."},{"key":"B63","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.humpath.2018.04.006","article-title":"Evaluation of the efficacy of the 4 tests (p16 immunochemistry, polymerase chain reaction, DNA, and RNA in situ hybridization) to evaluate a human papillomavirus infection in head and neck cancers: a cohort of 348 French squamous cell carcinomas.","volume":"78","author":"Augustin","year":"2018","journal-title":"Hum Pathol."},{"key":"B64","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.humpath.2019.05.006","article-title":"In situ hybridization for high-risk HPV E6\/E7 mRNA is a superior method for detecting transcriptionally active HPV in oropharyngeal cancer.","volume":"90","author":"Rand\u00e9n-Brady","year":"2019","journal-title":"Hum Pathol."},{"key":"B65","doi-asserted-by":"publisher","first-page":"1518","DOI":"10.1038\/modpathol.2015.113","article-title":"Diagnosis of HPV-driven head and neck cancer with a single test in routine clinical practice.","volume":"28","author":"Mirghani","year":"2015","journal-title":"Mod Pathol."},{"key":"B66","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1038\/modpathol.2011.91","article-title":"A comparison of clinically utilized human papillomavirus detection methods in head and neck cancer.","volume":"24","author":"Schlecht","year":"2011","journal-title":"Mod Pathol."},{"key":"B67","doi-asserted-by":"publisher","first-page":"344","DOI":"10.5858\/arpa.2019-0093-CP","article-title":"Comparative performance of high-risk human papillomavirus RNA and DNA in situ hybridization on college of american pathologists proficiency tests.","volume":"144","author":"Keung","year":"2019","journal-title":"Arch Pathol Lab Med."},{"key":"B68","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S0272-2712(18)30063-5","article-title":"In situ diagnosis of human papillomaviruses.","volume":"20","author":"Unger","year":"2000","journal-title":"Clin Lab Med."},{"key":"B69","doi-asserted-by":"publisher","first-page":"1874","DOI":"10.1097\/PAS.0b013e318265fb2b","article-title":"Detection of transcriptionally active high-risk HPV in patients with head and neck squamous cell carcinoma as visualized by a novel E6\/E7 mRNA in situ hybridization method.","volume":"36","author":"Bishop","year":"2012","journal-title":"Am J Surg Pathol."},{"key":"B70","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1038\/s41416-019-0414-9","article-title":"Recommendations for determining HPV status in patients with oropharyngeal cancers under TNM8 guidelines: a two-tier approach.","volume":"120","author":"Craig","year":"2019","journal-title":"Br J Cancer."},{"key":"B71","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1002\/ijc.27739","article-title":"A novel RT-PCR method for quantification of human papillomavirus transcripts in archived tissues and its application in oropharyngeal cancer prognosis.","volume":"132","author":"Gao","year":"2013","journal-title":"Int J Cancer."},{"key":"B72","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1111\/jop.12956","article-title":"A proposal for classification of oropharyngeal squamous cell carcinoma: morphology and status of HPV by immunohistochemistry and molecular biology.","volume":"49","author":"Rahimi","year":"2020","journal-title":"J Oral Pathol Med."},{"key":"B73","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.jmoldx.2011.08.002","article-title":"RNAscope: a novel in situ RNA analysis platform for formalin-fixed, paraffin-embedded tissues.","volume":"14","author":"Wang","year":"2012","journal-title":"J Mol Diagn."},{"key":"B74","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/978-1-4939-1459-3_16","article-title":"Quantitative ultrasensitive bright-field RNA in situ hybridization with RNAscope.","volume":"1211","author":"Wang","year":"2014","journal-title":"Methods Mol Biol."},{"key":"B75","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1038\/s41379-019-0410-x","article-title":"MYCN RNA levels determined by quantitative in situ hybridization is better than MYCN gene dosages in predicting the prognosis of neuroblastoma patients.","volume":"33","author":"Chang","year":"2019","journal-title":"Mod Pathol."},{"key":"B76","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1097\/PAS.0000000000000516","article-title":"Performance of a branch chain RNA in situ hybridization assay for the detection of high-risk human papillomavirus in head and neck squamous cell carcinoma.","volume":"39","author":"Kerr","year":"2015","journal-title":"Am J Surg Pathol."},{"key":"B77","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.oraloncology.2016.02.008","article-title":"RNA in-situ hybridization is a practical and effective method for determining HPV status of oropharyngeal squamous cell carcinoma including discordant cases that are p16 positive by immunohistochemistry but HPV negative by DNA in-situ hybridization.","volume":"55","author":"Rooper","year":"2016","journal-title":"Oral Oncol."},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1016\/j.oraloncology.2019.104488","article-title":"HPV33+ HNSCC is associated with poor prognosis and has unique genomic and immunologic landscapes.","volume":"100","author":"Chatfield-Reed","year":"2020","journal-title":"Oral Oncol."},{"key":"B79","doi-asserted-by":"publisher","first-page":"1882","DOI":"10.1002\/ijc.24911","article-title":"Biological and clinical relevance of transcriptionally active human papillomavirus (HPV) infection in oropharynx squamous cell carcinoma.","volume":"126","author":"Jung","year":"2010","journal-title":"Int J Cancer."},{"key":"B80","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1093\/jnci\/djh183","article-title":"Genetic patterns in head and neck cancers that contain or lack transcriptionally active human papillomavirus.","volume":"96","author":"Braakhuis","year":"2004","journal-title":"J Natl Cancer Inst."},{"key":"B81","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1097\/PAS.0b013e318253a2d1","article-title":"Validation of methods for oropharyngeal cancer HPV status determination in US cooperative group trials.","volume":"36","author":"Jordan","year":"2012","journal-title":"Am J Surg Pathol."},{"key":"B82","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1097\/PAS.0b013e318220e59d","article-title":"High-risk human papillomavirus E6\/E7 mRNA detection by a novel in situ hybridization assay strongly correlates with p16 expression and patient outcomes in oropharyngeal squamous cell carcinoma.","volume":"35","author":"Ukpo","year":"2011","journal-title":"Am J Surg Pathol."},{"key":"B83","doi-asserted-by":"publisher","first-page":"6213","DOI":"10.1200\/JCO.2009.23.1670","article-title":"Comparative prognostic value of HPV16 E6 mRNA compared with in situ hybridization for human oropharyngeal squamous carcinoma.","volume":"27","author":"Shi","year":"2009","journal-title":"J Clin Oncol."},{"key":"B84","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.1038\/s41379-018-0090-y","article-title":"HPV RNA CISH score identifies two prognostic groups in a p16 positive oropharyngeal squamous cell carcinoma population.","volume":"31","author":"Augustin","year":"2018","journal-title":"Mod Pathol."},{"key":"B85","doi-asserted-by":"publisher","first-page":"4350","DOI":"10.1073\/pnas.93.9.4350","article-title":"Inhibition of cyclin D-CDK4\/CDK6 activity is associated with an E2F-mediated induction of cyclin kinase inhibitor activity.","volume":"93","author":"Khleif","year":"1996","journal-title":"Proc Natl Acad Sci USA."},{"key":"B86","doi-asserted-by":"publisher","first-page":"2366","DOI":"10.1002\/ijc.28580","article-title":"Molecular characterization of p16-immunopositive but HPV DNA-negative oropharyngeal carcinomas.","volume":"134","author":"Rietbergen","year":"2014","journal-title":"Int J Cancer."},{"key":"B87","doi-asserted-by":"publisher","first-page":"4993","DOI":"10.1158\/0008-5472.CAN-11-3934","article-title":"Viral RNA patterns and high viral load reliably define oropharynx carcinomas with active HPV16 involvement.","volume":"72","author":"Holzinger","year":"2012","journal-title":"Cancer Res."},{"key":"B88","doi-asserted-by":"publisher","first-page":"S450","DOI":"10.1245\/s10434-012-2778-4","article-title":"HPV status of oropharyngeal cancer by combination HPV DNA\/p16 testing: biological relevance of discordant results.","author":"Hong","year":"2013","journal-title":"Ann Surg Oncol."},{"key":"B89","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1007\/s12105-012-0382-3","article-title":"Equivocal p16 immunostaining in squamous cell carcinoma of the head and neck: staining patterns are suggestive of HPV status.","volume":"6","author":"Chen","year":"2012","journal-title":"Head Neck Pathol."},{"key":"B90","first-page":"132","article-title":"Prognostic significance of p16 cellular localization in oropharyngeal squamous cell carcinoma.","volume":"46","author":"Lai","year":"2016","journal-title":"Ann Clin Lab Sci."},{"key":"B91","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1038\/bjc.2012.264","article-title":"Different cellular p16(INK4a) localisation may signal different survival outcomes in head and neck cancer.","volume":"107","author":"Zhao","year":"2012","journal-title":"Br J Cancer."},{"key":"B92","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/j.humpath.2013.09.006","article-title":"African Americans with oropharyngeal carcinoma have significantly poorer outcomes despite similar rates of human papillomavirus-mediated carcinogenesis.","volume":"45","author":"Isayeva","year":"2014","journal-title":"Hum Pathol."},{"key":"B93","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1093\/annonc\/mdy060","article-title":"Evaluation of the eighth TNM classification on p16-positive oropharyngeal squamous cell carcinomas in the Netherlands and the importance of additional HPV DNA testing.","volume":"29","author":"Nauta","year":"2018","journal-title":"Ann Oncol."},{"key":"B94","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.ejca.2014.10.016","article-title":"Incidence of human papillomavirus positive tonsillar and base of tongue carcinoma: a stabilisation of an epidemic of viral induced carcinoma?","volume":"51","author":"N\u00e4sman","year":"2015","journal-title":"Eur J Cancer."},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1186\/s40463-018-0298-3","article-title":"Prognostic significance of cell cycle-associated proteins p16, pRB, cyclin D1 and p53 in resected oropharyngeal carcinoma.","volume":"47","author":"Plath","year":"2018","journal-title":"J Otolaryngol Head Neck Surg."},{"key":"B96","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1038\/modpathol.2017.31","article-title":"p16 immunohistochemistry in oropharyngeal squamous cell carcinoma: a comparison of antibody clones using patient outcomes and high-risk human papillomavirus RNA status.","volume":"30","author":"Shelton","year":"2017","journal-title":"Mod Pathol."},{"key":"B97","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1200\/JOP.18.00433","article-title":"Human papillomavirus testing in head and neck carcinomas: ASCO clinical practice guideline endorsement summary of the CAP guideline.","volume":"14","author":"Fakhry","year":"2018","journal-title":"J Oncol Pract."},{"key":"B98","doi-asserted-by":"publisher","first-page":"S90","DOI":"10.1017\/S0022215116000505","article-title":"Oropharyngeal cancer: United Kingdom national multidisciplinary guidelines.","volume":"130","author":"Mehanna","year":"2016","journal-title":"J Laryngol Otol."},{"key":"B99","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.oraloncology.2016.01.002","article-title":"Is p16-positive oropharyngeal squamous cell carcinoma associated with favorable prognosis? A systematic review and meta-analysis.","volume":"54","author":"Sedghizadeh","year":"2016","journal-title":"Oral Oncol."},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-16918-w","article-title":"Meta analysis: HPV and p16 pattern determines survival in patients with HNSCC and identifies potential new biologic subtype.","volume":"7","author":"Albers","year":"2017","journal-title":"Sci Rep."},{"key":"B101","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.oraloncology.2016.09.005","article-title":"Effect of HPV on head and neck cancer patient survival, by region and tumor site: a comparison of 1362 cases across three continents.","volume":"62","author":"D\u2019Souza","year":"2016","journal-title":"Oral Oncol."},{"key":"B102","doi-asserted-by":"publisher","first-page":"2993","DOI":"10.1002\/cncr.31385","article-title":"Increasing prevalence of human papillomavirus-positive oropharyngeal cancers among older adults.","volume":"124","author":"Windon","year":"2018","journal-title":"Cancer."},{"key":"B103","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1200\/JCO.2004.00.3335","article-title":"Molecular classification identifies a subset of human papillomavirus\u2013associated oropharyngeal cancers with favorable prognosis.","volume":"24","author":"Weinberger","year":"2006","journal-title":"J Clin Oncol."},{"key":"B104","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1001\/jamaoncol.2016.3067","article-title":"Differences in the prevalence of human papillomavirus (HPV) in head and neck squamous cell cancers by sex, race, anatomic tumor site, and HPV detection method.","volume":"3","author":"D\u2019Souza","year":"2017","journal-title":"JAMA Oncol."},{"key":"B105","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.1002\/cncr.30353","article-title":"The prognostic role of sex, race, and human papillomavirus in oropharyngeal and nonoropharyngeal head and neck squamous cell cancer.","volume":"123","author":"Fakhry","year":"2017","journal-title":"Cancer."},{"key":"B106","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.amjoto.2016.09.007","article-title":"Prognostic significance of p16 in squamous cell carcinoma of the larynx and hypopharynx.","volume":"38","author":"Meshman","year":"2017","journal-title":"Am J Otolaryngol."},{"key":"B107","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1200\/JCO.2015.62.5970","article-title":"Association of human papillomavirus and p16 status with outcomes in the IMCL-9815 phase III registration trial for patients with locoregionally advanced oropharyngeal squamous cell carcinoma of the head and neck treated with radiotherapy with or without cetuximab.","volume":"34","author":"Rosenthal","year":"2016","journal-title":"J Clin Oncol."},{"key":"B108","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1093\/annonc\/mdt574","article-title":"Impact of tumor HPV status on outcome in patients with recurrent and\/or metastatic squamous cell carcinoma of the head and neck receiving chemotherapy with or without cetuximab: retrospective analysis of the phase III EXTREME trial.","volume":"25","author":"Vermorken","year":"2014","journal-title":"Ann Oncol."},{"key":"B109","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/S1470-2045(13)70181-5","article-title":"Cisplatin and fluorouracil with or without panitumumab in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck (SPECTRUM): an open-label phase 3 randomised trial.","volume":"14","author":"Vermorken","year":"2013","journal-title":"Lancet Oncol."},{"key":"B110","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1038\/s41416-018-0131-9","article-title":"Efficacy and safety of pembrolizumab in recurrent\/metastatic head and neck squamous cell carcinoma: pooled analyses after long-term follow-up in KEYNOTE-012.","volume":"119","author":"Mehra","year":"2018","journal-title":"Br J Cancer."},{"key":"B111","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1016\/S1470-2045(16)30066-3","article-title":"Safety and clinical activity of pembrolizumab for treatment of recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-012): an open-label, multicentre, phase 1b trial.","volume":"17","author":"Seiwert","year":"2016","journal-title":"Lancet Oncol."},{"key":"B112","doi-asserted-by":"publisher","first-page":"1856","DOI":"10.1056\/NEJMoa1602252","article-title":"Nivolumab for recurrent squamous-cell carcinoma of the head and neck.","volume":"375","author":"Ferris","year":"2016","journal-title":"N Engl J Med."},{"key":"B113","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.oraloncology.2018.04.008","article-title":"Nivolumab vs investigator\u2019s choice in recurrent or metastatic squamous cell carcinoma of the head and neck: 2-year long-term survival update of CheckMate 141 with analyses by tumor PD-L1 expression.","volume":"81","author":"Ferris","year":"2018","journal-title":"Oral Oncol."},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.01676","article-title":"E6\/E7 and E6\u2217 From HPV16 and HPV18 Upregulate IL-6 expression independently of p53 in keratinocytes.","volume":"10","author":"Artaza-Irigaray","year":"2019","journal-title":"Front Immunol."},{"key":"B115","doi-asserted-by":"publisher","first-page":"5011","DOI":"10.1158\/0008-5472.CAN-18-0118","article-title":"Combined blockade of IL6 and PD-1\/PD-L1 signaling abrogates mutual regulation of their immunosuppressive effects in the tumor microenvironment.","volume":"78","author":"Tsukamoto","year":"2018","journal-title":"Cancer Res."},{"key":"B116","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1002\/cjp2.47","article-title":"Circulating human papillomavirus DNA detected using droplet digital PCR in the serum of patients diagnosed with early stage human papillomavirus-associated invasive carcinoma.","volume":"2","author":"Jeannot","year":"2016","journal-title":"J Pathol Clin Res."},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.98811","article-title":"Frameshift events predict anti-PD-1\/L1 response in head and neck cancer.","volume":"3","author":"Hanna","year":"2018","journal-title":"JCI Insight."},{"key":"B118","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1093\/jnci\/djt053","article-title":"Human papillomavirus infections and upper aero-digestive tract cancers: the ARCAGE study.","volume":"105","author":"Anantharaman","year":"2013","journal-title":"J Natl Cancer Inst."},{"key":"B119","doi-asserted-by":"publisher","first-page":"2708","DOI":"10.1200\/JCO.2012.47.2738","article-title":"Evaluation of human papillomavirus antibodies and risk of subsequent head and neck cancer.","volume":"31","author":"Kreimer","year":"2013","journal-title":"J Clin Oncol."},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djx005","article-title":"Kinetics of the human papillomavirus type 16 E6 antibody response prior to oropharyngeal cancer.","volume":"109","author":"Kreimer","year":"2017","journal-title":"J Natl Cancer Inst."},{"key":"B121","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1158\/1055-9965.EPI-14-1217","article-title":"Human papillomavirus 16 E6 antibodies in individuals without diagnosed cancer: a pooled analysis.","volume":"24","author":"Lang Kuhs","year":"2015","journal-title":"Cancer Epidemiol Biomarkers Prev."},{"key":"B122","doi-asserted-by":"publisher","first-page":"2748","DOI":"10.1002\/ijc.30697","article-title":"Sensitivity and specificity of antibodies against HPV16 E6 and other early proteins for the detection of HPV16-driven oropharyngeal squamous cell carcinoma.","volume":"140","author":"Holzinger","year":"2017","journal-title":"Int J Cancer."},{"key":"B123","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.canep.2016.03.003","article-title":"Characterization of human papillomavirus antibodies in individuals with head and neck cancer.","volume":"42","author":"Lang Kuhs","year":"2016","journal-title":"Cancer Epidemiol."},{"key":"B124","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.oraloncology.2017.05.010","article-title":"Evaluation of type-specific antibodies to high risk-human papillomavirus (HPV) proteins in patients with oropharyngeal cancer.","volume":"70","author":"Broglie","year":"2017","journal-title":"Oral Oncol."},{"key":"B125","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.oraloncology.2018.05.015","article-title":"Biomarkers for early identification of recurrences in HPV-driven oropharyngeal cancer.","volume":"82","author":"Mirghani","year":"2018","journal-title":"Oral Oncol."},{"key":"B126","doi-asserted-by":"publisher","first-page":"4382","DOI":"10.1002\/cncr.30966","article-title":"Human papillomavirus 16 E6 antibodies are sensitive for human papillomavirus-driven oropharyngeal cancer and are associated with recurrence.","volume":"123","author":"Lang Kuhs","year":"2017","journal-title":"Cancer."},{"key":"B127","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1056\/NEJMra1706174","article-title":"Application of cell-free DNA analysis to cancer treatment.","volume":"379","author":"Corcoran","year":"2018","journal-title":"N Engl J Med."},{"key":"B128","doi-asserted-by":"publisher","first-page":"5910","DOI":"10.1002\/cam4.1832","article-title":"The prognostic significance of circulating tumor cells in head and neck and non-small-cell lung cancer.","volume":"7","author":"Kulasinghe","year":"2018","journal-title":"Cancer Med."},{"key":"B129","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1158\/0008-5472.CAN-18-1082","article-title":"Early noninvasive detection of response to targeted therapy in non-small cell lung cancer.","volume":"79","author":"Phallen","year":"2019","journal-title":"Cancer Res."},{"key":"B130","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1200\/JCO.19.02444","article-title":"Plasma circulating tumor HPV DNA for the surveillance of cancer recurrence in HPV-associated oropharyngeal cancer.","volume":"38","author":"Chera","year":"2020","journal-title":"J Clin Oncol."},{"key":"B131","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/978-1-4939-7778-9_4","article-title":"Control materials and digital PCR methods for evaluation of circulating cell-free DNA extractions from plasma.","volume":"1768","author":"Whale","year":"2018","journal-title":"Methods Mol Biol."},{"key":"B132","doi-asserted-by":"publisher","first-page":"122","DOI":"10.3322\/caac.21389","article-title":"Head and neck cancers-major changes in the American Joint Committee on cancer eighth edition cancer staging manual.","volume":"67","author":"Lydiatt","year":"2017","journal-title":"CA Cancer J Clin."},{"key":"B133","doi-asserted-by":"publisher","first-page":"4682","DOI":"10.1158\/1078-0432.CCR-19-0211","article-title":"Rapid clearance profile of plasma circulating tumor HPV type 16 DNA during chemoradiotherapy correlates with disease control in HPV-associated oropharyngeal cancer.","volume":"25","author":"Chera","year":"2019","journal-title":"Clin Cancer Res."},{"key":"B134","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1038\/nature21386","article-title":"Integrated genomic and molecular characterization of cervical cancer.","volume":"543","year":"2017","journal-title":"Nature."},{"key":"B135","doi-asserted-by":"publisher","DOI":"10.1038\/npjgenmed.2016.4","article-title":"Mechanistic signatures of HPV insertions in cervical carcinomas.","volume":"1","author":"Holmes","year":"2016","journal-title":"NPJ Genom Med."},{"key":"B136","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1158\/0008-5472.CAN-07-2754","article-title":"Type-dependent integration frequency of human papillomavirus genomes in cervical lesions.","volume":"68","author":"Vinokurova","year":"2008","journal-title":"Cancer Res."},{"key":"B137","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1002\/ijc.22481","article-title":"High grade cervical lesions are caused preferentially by non-European variants of HPVs 16 and 18.","volume":"120","author":"Sichero","year":"2007","journal-title":"Int J Cancer."},{"key":"B138","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1128\/JCM.36.7.2046-2051.1998","article-title":"The L1 major capsid protein of human papillomavirus type 16 variants affects yield of virus-like particles produced in an insect cell expression system.","volume":"36","author":"Touze","year":"1998","journal-title":"J Clin Microbiol."},{"key":"B139","doi-asserted-by":"publisher","DOI":"10.3390\/cancers11121846","article-title":"Mechanistic signatures of human papillomavirus insertions in anal squamous cell carcinomas.","volume":"11","author":"Morel","year":"2019","journal-title":"Cancers (Basel)."}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fonc.2020.01751\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,15]],"date-time":"2020-09-15T11:26:50Z","timestamp":1600169210000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fonc.2020.01751\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,15]]},"references-count":139,"alternative-id":["10.3389\/fonc.2020.01751"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2020.01751","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,15]]},"article-number":"1751"}}